Salipro Biotech AB and Icosagen, both biotech companies, have entered into a multi-target antibody research agreement to advance drug discovery programs against several challenging membrane proteins, including G protein-coupled receptors (GPCRs) and solute carrier (SLC) transporters. The partnership between will build on Salipro’s collaboration and licensing agreements with leading pharma and biotech companies to enable drug discovery against complex membrane protein targets, ranging fr...